The Fight against COVID-19
As the pandemic continues, Sanofi is at the forefront of vaccine development, while carrying on the daily business of making and delivering medicines for patients.
Working to Prevent Respiratory Syncytial Virus in All Infants
The virus is so pervasive it threatens every child in their first years of life.
Partnering for the Future
Driven by the Science: <br/>Multi-specific antibodies
-
Press releases2020-07-31MMMM DD YYYYSanofi and GSK in advanced discussions with European Union to supply up to 300 million doses of COVID-19 vaccine